Solid/Semi-Solid Dosage

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Technical, regulatory, and personnel considerations characterize pharmaceutical compounding.

Matching excipients to API properties is essential.

The acquisition of Qualicaps reflects a strategic investment that aims to strengthen Roquette’s global standing in oral dosage solutions.

Dosage forms are being shaped by numerous factors, with patient-centricity continuing to be an important driver of decisions in development.

The biggest hurdle is developing palatable formulations that are efficacious and patient friendly.

Current good manufacturing practices for oral solid dosage forms protect the product from contamination and potential errors.

Felicity Thomas, European/Senior Editor, Pharm Tech Group, and Andy Dumelow, Head of Technical Sales, I Holland, chat about tablet tooling maintenance in this brief podcast.

A good understanding of tablet tooling and how to properly maintain these key parts will maximize lifespan of tools.

Despite the advantages intensified processes can offer developers, there are still some obstacles to overcome before broader application of new technologies will be implemented.

This article discusses the evaluation of paired content uniformity and weight variation data sets using F and T tests to ensure that batches meet compendial requirements.

Quotient Sciences’ facility expansion is designed to increase support for fully integrated drug development programs.

Webinar Date/Time: Thu, Oct 27, 2022 11:00 AM EDT

Materials enhance sustainability and efficiency.

Manufacturers must consider key components of manufacturing solid versus semi-solid drugs to create a successful end product.

Advancements in soft capsule technology can enable the development of soft capsule formulations, which are becoming the preferred method of oral administration.

This article introduces a control chart technique using F statistic for continued process verification of oral solid dosage forms.

Creating building blocks for good manufacturing practices is essential.

This article is focused on introducing a control chart technique using relative standard deviation (RSD) statistics (i.e., RSD chart); in other words, a coefficient of variation chart for continued process verification.

Dissolution testing has seen recent trends that have led to increased data integrity solutions as well as an increase in biorelevant testing techniques.

The latest manufacturing technologies are essential for helping pharmaceutical formulators meet up-and-coming trends in OSD treatments.

By following some fundamental steps, manufacturers can optimize their tablet tooling maintenance and resulting productivity.

With the majority of large pharmaceutical manufacturers aiming for carbon neutrality by 2030, reusable packaging remains a largely untapped approach in achieving measurable ESG gains.

The author introduces a practical approach to determining the best estimate of probability for passing multiple stage dissolution tests.

Collaboration and new tools aid efforts to implement new processing technologies for small-molecule drug product manufacturing.

Innovations address supply-chain constraints, serialization, and new requirements for sustainable and patient-centric designs.

Innovations address sustainable and patient-centric designs.

Process performance metrics of eight different mechanical devices were assessed to evaluate compliance with regulatory and compendial criteria.

Smart manufacturing transforms management of tablet and capsule equipment and processes.